source
- Lupin spins out two phase-1 cancer candidates into US startup Kaveri, taking majority stake and providing seed fundingLupin, an Indian generics manufacturer, has created a U.S.-based spinout called Kaveri Therapeutics by transferring two clinical-phase cancer drug candidates. The assets are a PRMT5 inhibitor (LNP…
- Novo Nordisk files lawsuit against Eli Lilly over allegedly deceptive GLP-1 dose adsNovo Nordisk has initiated legal action against Eli Lilly in a U.S. court, alleging that Lilly's recent advertisements misrepresent the dosing of GLP-1 obesity treatments. The company says the ads…